Selecting primary packaging for parenterals

Despite the proliferation of new drug delivery systems for parenteral products, glass vials remain the most widely used primary containers worldwide. This trend is expected to continue for several years, with global demand for glass vials projected to rise to $5.7 billion in 2024.
With glass and polymers offering advantages and limitations in different scenarios, many factors must be considered to determine the better choice. Some pros and cons are listed in this article. Commercializing new primary packaging for parenteral products tends to be time-consuming due to the complex regulatory approval procedures that must be followed to adopt a new packaging material (PharmTech, 2 July 2018).
Click here to read the full article.
Click here for more information about the NVC project Pharmaceutical Packaging Innovation.
Click here for more information about the Live Online NVC E-Course Pharmaceutical Packaging.

This news item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.